leadf
logo-loader
viewKanabo Group PLC

Kanabo Research sets sights on London listing

Israeli-based Kanabo Research could become the first cannabis firm to list on the main market of the London Stock Exchange.
The company, which has developed a vaporiser for the inhalation of medical cannabis, is planning to list through a reverse takeover by cash shell Spinnaker Opportunities.
Spinnaker has signed a head of terms to buy Kanabo and the deal is waiting on UK approval.
Chief executive Avihu Tamir sat down with Proactive’s Andrew Scott to talk about the deal and Kanabo's move towards the commercialisation of its VapePod device.

Quick facts: Kanabo Group PLC

Price: 22.1 GBX

LSE:KNB
Market: LSE
Market Cap: £76.55 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Savannah Resources' says Mina do Barroso is 'right project, right mineral,...

Savannah Resources PLC's (LON:SAV) David Archer presents his latest findings from their ongoing metallurgical test work programme at its Mina do Barroso lithium project in Portugal to Proactive London.  Archer explains that the results highlighted the potential for lower capital and...

1 hour, 2 minutes ago

2 min read